W. David

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

D. Papanicolaou, V. S. Williams, P. Bergh, 2019, The Lancet Neurology.

Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophies

R. Griggs, P. Narayanaswami, G. Gronseth, 2014, Neurology.

Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophies

R. Griggs, P. Narayanaswami, G. Gronseth, 2014, Neurology.